Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets
상품코드:1735430
리서치사:BCC Research
발행일:2025년 05월
페이지 정보:영문 155 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 OTC 의약품, 비타민 및 식이보충제 시장 규모는 2025년 2,769억 달러에서 2030년 말 3,717억 달러로 확대될 것으로 예상되며, 2025년부터 2030년까지 6.1%의 연평균 성장률을 보일 것으로 예측됩니다.
아시아태평양 시장 규모는 2025년 1,202억 달러에서 2030년 말 1,723억 달러로 확대될 것으로 예상되며, 같은 기간 동안 7.5%의 CAGR을 기록할 것으로 예상됩니다.
북미 시장 규모는 2025년 753억 달러에서 2030년 말 937억 달러로 확대될 것으로 예상되며, 같은 기간 동안 4.5%의 CAGR을 기록할 것으로 전망됩니다.
세계의 OTC 의약품, 비타민 및 식이보충제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법·규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
조사 범위
시장 요약
제2장 시장 개요
시장 정의
OTC 의약품
비타민 및 식이보충제
업계 개요
거시경제 분석
Porter's Five Forces 분석
제3장 시장 역학
시장 성장 촉진요인
셀프 케어와 예방 케어에 대한 추세 상승
인구통계 변화에 의한 고령화
공중위생 시스템에 대한 압력 상승
프리미엄화와 혁신이 가격 설정을 추진
온라인 판매 채널 증가와 원격의료 플랫폼 성장
시장 성장 억제요인
자체브랜드 입수 가능성과 수용성 향상
대체품의 위협
대체 수단의 존재
계절성의 영향
시장 기회
신흥 국가의 중산층 확대
여성 건강과 인지 기능 서포트 제품 수요 증가
허브나 유기농 제품으로의 이동
E-Commerce와 소비자 직판
중요 포인트
제4장 규제 상황
미국
OTC 의약품
비타민 및 식이보충제
유럽
OTC 의약품
비타민 및 식이보충제
아시아태평양
OTC 의약품
비타민 및 식이보충제
제5장 신기술과 개발
성분 표시에 대한 의식 향상
혁신에 의한 브랜드 확장
처방약에서 OTC 의약품으로의 교체
제6장 시장 세분화 분석
세분화 내역
OTC 의약품, 비타민 및 식이보충제 시장 : 제품 유형별
비타민 및 식이보충제
시장 개요
중요 포인트
시장 매출·예측
비타민 및 식이보충제 시장 : 판매 장소별
소매 약국·점포
E-Commerce
기타
OTC 의약품
시장 개요
중요 포인트
시장 매출·예측 : 제품 유형별
호흡기 치료
통증 완화
소화기계 건강
피부과약
구강 의료
아이케어
금연
OTC 의약품 시장 : 판매 장소별
소매 약국·점포
온라인 약국
지역적 내역
OTC 의약품, 비타민 및 식이보충제 시장 : 지역별
중요 포인트
북미
유럽
아시아태평양
중동 및 아프리카
남미
제7장 경쟁 정보
중요 포인트
OTC 의약품
비타민 및 식이보충제
주요 전개와 전략
제8장 OTC 의약품, 비타민 및 식이보충제 시장의 지속가능성 : ESG 관점
ESG : 소개
환경
사회
거버넌스
ESG 리스크 평가
결론
제9장 부록
조사 방법
정보 출처
약어
기업 개요
ABBOTT
AMWAY CORP.
BAYER AG
DSM- FIRMENICH
HALEON GROUP OF CO.
HERBALIFE LTD.
KENVUE
NESTLE HEALTH SCIENCE
OPELLA HEALTHCARE GROUP SAS
PHARMAVITE
PROCTER & GAMBLE
RECKITT
STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
신흥 스타트업 기업/시장 디스럽터
ksm
영문 목차
영문목차
The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
The Asia-Pacific market for OTC drugs, vitamins and dietary supplements is expected to grow from $120.2 billion in 2025 and is projected to reach $172.3 billion by the end of 2030, at a CAGR of 7.5% during the forecast period of 2025 to 2030.
The North American market for OTC drugs, vitamins and dietary supplements is expected to grow from $75.3 billion in 2025 and is projected to reach $93.7 billion by the end of 2030, at a CAGR of 4.5% during the forecast period of 2025 to 2030.
Report Scope
This report provides an overview of the global over-the-counter (OTC) drugs, vitamins and dietary supplements market and analyzes trends in this market. It includes global revenue ($ million) for the base year of 2024, estimated market values for 2025, and market values for the forecast period 2025 through 2030. In this report, market revenue refers to ex-factory or ex-manufacturer sales, representing the value of goods as they leave the manufacturer and before any markups by wholesalers or retailers.
The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.
The report concludes with an analysis of the competitive landscape of this market, providing the ranking and share of key players. It also has a company profiles section that is dedicated to providing details about leading market players.
It is important to note that this report's scope covers only pharmacological OTC drugs and excludes any other types of drugs, such as alternative therapies. Also, dietary supplements for weight management, meal replacements, medical nutrition, sports nutrition, and skin care are not included in this report.
Report Includes
46 data tables and 59 additional tables
An overview of the global market for over-the-counter drugs, vitamins and dietary supplements
An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Highlights of the current and future market potential and quantification of the market by product type, point of sales, and geographic region
Discussion on market opportunities for over-the-counter drugs, vitamins and dietary supplement applications, industry structure, and regulatory scenarios
Information on the latest developments in healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Comprehensive company profiles of the leading players of the industry, including Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer AG, and Procter & Gamble
Table of Contents
Chapter 1 Executive Summary
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Definitions
Over-the-counter (OTC) Drugs
Vitamins and Dietary Supplements
Industry Overview
Macroeconomic Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers (High)
Bargaining Power of Suppliers (Moderate to Low)
Threat of New Entrants (Moderate)
Threat of Substitutes (Low)
Industry Competition (High)
Chapter 3 Market Dynamics
Market Drivers
Increasing Trend Toward Self-Care and Preventive Care
Changing Demographics Resulting in Aging Population
Increasing Pressure on Public Health Systems
Premiumization and Innovation Driving Pricing
Rising Online Sales Channels and Growth of Telehealth Platforms
Market Restraints
Increases in the Availability and Acceptance of Private-Label Brands
Threat from Counterfeit Products
Presence of Alternative Methods
Impact of Seasonality
Market Opportunities
Growing Middle Class in Emerging Economies
Growing Demand for Women's Health and Cognitive Health Support Products
Shift Toward Herbal and Organic Products
E-Commerce and Direct-to-Consumer Sales
Key Takeaways
Chapter 4 Regulatory Landscape
U.S.
OTC Drugs
Vitamins and Dietary Supplements
Europe
OTC Drugs
Vitamins and Dietary Supplements
Asia-Pacific
OTC Drugs
Vitamins and Dietary Supplements
Chapter 5 Emerging Technologies and Developments
Increased Awareness of Ingredient Labeling
Brand Extension Fueled by Innovation
Rx-to-OTC Switch
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Product Type
Vitamins and Dietary Supplements
Market Overview
Key Takeaways
Market Revenue and Forecast
Vitamins and Dietary Supplements Market, by Point of Sale
Retail Pharmacies and Stores
E-Commerce
Other Points of Sales
OTC Drugs
Market Overview
Key Takeaways
Market Revenue and Forecast, by Product Type
Respiratory Treatments
Pain Relief
Digestive Health
Dermatological Drugs
Oral Medical Care
Eye Care
Smoking Cessation
OTC Drugs Market, by Point of Sale
Retail Pharmacies and Stores
E-Pharmacies
Geographic Breakdown
OTC Drugs, Vitamins and Dietary Supplements Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Key Takeaways
OTC Drugs
Vitamins and Dietary Supplements
Key Developments and Strategies
Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective
